can semaglutide prevent dementia Popular diabetes and weight-loss drug may reduce risk of | CWRU Newsroom Frontiers | Semaglutide in cognitive

However, weight loss isnt always linear, and its never the same for everyone

After 48 weeks, participants lost an average of 15.6% of their weight, and about 75% of the lost weight was fat a favorable ratio comparable to whats seen in people who manage to lose weight through improved diet and exercise

Once treatment stops, the medications impact on digestion and appetite fades

Body Composition and Metabolic Parameters Research on component peptides revealed favorable effects on body composition and metabolic markers[10]: Significant reductions in waist circumference (10-15 cm reductions observed) Preferential visceral fat loss documented through imaging studies Preserved lean body mass relative to total weight loss in most studies Improved body composition ratios with fat mass reductions exceeding total weight loss percentages Type 2 Diabetes Research Glycemic Control Studies Investigations in type 2 diabetes models demonstrated robust glucose-lowering effects[11]: HbA1c reductions of 2.0-2.4% observed with GLP3 in phase 2 diabetes trials Fasting plasma glucose reductions of 40-60 mg/dL documented across dose ranges Improved continuous glucose monitoring parameters including time in range and glucose variability CagriSema combination achieved superior glycemic control compared to individual components Studies showed that 72% of participants with prediabetes reverted to normoglycemia with GLP3 treatment, suggesting potential diabetes prevention applications[12]

Ozempic for weight loss is available at the Primary Care Center of Clear Lake